268 related articles for article (PubMed ID: 32677996)
61. Outcomes of transconjunctival sutureless 27-gauge micro-incision vitrectomy surgery in diabetic vitreous haemorrhage.
Shahzadi B; Rizwi SF; Qureshi FM; Latif K; Mahmood SA
Pak J Med Sci; 2017; 33(1):86-89. PubMed ID: 28367178
[TBL] [Abstract][Full Text] [Related]
62. Use of pegaptanib for recurrent and non-clearing vitreous haemorrhage in proliferative diabetic retinopathy.
Hornan D; Edmeades N; Krishnan R; Khan J; Lochhead J
Eye (Lond); 2010 Aug; 24(8):1315-9. PubMed ID: 20224599
[TBL] [Abstract][Full Text] [Related]
63. Long-term results of vitreous surgery for proliferative diabetic retinopathy.
Sima P; Zoran T
Doc Ophthalmol; 1994; 87(3):223-32. PubMed ID: 7835192
[TBL] [Abstract][Full Text] [Related]
64. Entry site neovascularization and vitreous cavity hemorrhage after diabetic vitrectomy. The predictive value of inner sclerostomy site ultrasonography.
Steel DH; Habib MS; Park S; Hildreth AJ; Owen RI
Ophthalmology; 2008 Mar; 115(3):525-32. PubMed ID: 17976729
[TBL] [Abstract][Full Text] [Related]
65. Vitrectomy in diabetic patients with a blind fellow eye.
Bodanowitz S; Hesse L; Weinand F; Kroll P
Acta Ophthalmol Scand; 1996 Feb; 74(1):84-8. PubMed ID: 8689491
[TBL] [Abstract][Full Text] [Related]
66. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
67. Xenon-arc endophotocoagulation during vitrectomy for diabetic vitreous haemorrhage.
Ficker LA; Passani F; Leaver PK; McLeod D
Graefes Arch Clin Exp Ophthalmol; 1986; 224(5):423-7. PubMed ID: 3758687
[TBL] [Abstract][Full Text] [Related]
68. Ultrasonic fragmentation for removing thick organized clots during diabetic vitrectomy - A novel technique.
Singh DV; Reddy RR; Upadhyay A; Sharma YR
Indian J Ophthalmol; 2022 Jun; 70(6):2184-2186. PubMed ID: 35648011
[TBL] [Abstract][Full Text] [Related]
69. Ultrasound biomicroscopy of sclerotomy sites after pars plana vitrectomy for diabetic vitreous hemorrhage.
Bhende M; Agraharam SG; Gopal L; Sumasri K; Sukumar B; George J; Sharma T; Shanmugam MP; Bhende PS; Shetty NS; Agrawal RN; Deshpande DA
Ophthalmology; 2000 Sep; 107(9):1729-36. PubMed ID: 10964837
[TBL] [Abstract][Full Text] [Related]
70. Entry site treatment to prevent late recurrent postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Steel DH; Connor A; Habib MS; Owen R
Br J Ophthalmol; 2010 Sep; 94(9):1219-25. PubMed ID: 19955203
[TBL] [Abstract][Full Text] [Related]
71. Long-term outcomes of sutureless 25-G+ pars-plana vitrectomy for the management of diabetic tractional retinal detachment.
Mikhail M; Ali-Ridha A; Chorfi S; Kapusta MA
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):255-261. PubMed ID: 27480177
[TBL] [Abstract][Full Text] [Related]
72. Effect of intravitreal triamcinolone acetonide injection at the end of vitrectomy for vitreous haemorrhage related to proliferative diabetic retinopathy.
Takamura Y; Shimura M; Katome T; Someya H; Sugimoto M; Hirano T; Sakamoto T; Gozawa M; Matsumura T; Inatani M;
Br J Ophthalmol; 2018 Oct; 102(10):1351-1357. PubMed ID: 29343528
[TBL] [Abstract][Full Text] [Related]
73. [Vitreous hemorrhage: attitudes in therapy, vitrectomy].
Mathis A; Pagot V; Malecaze F
Diabete Metab; 1993; 19(5):436-40. PubMed ID: 8056123
[TBL] [Abstract][Full Text] [Related]
74. A two-year prospective study comparing lidocaine 2% jelly versus peribulbar anaesthesia for 25G and 23G sutureless vitrectomy.
Theocharis IP; Alexandridou A; Tomic Z
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1253-8. PubMed ID: 17342504
[TBL] [Abstract][Full Text] [Related]
75. Vitreous hemorrhage after vitrectomy for diabetic retinopathy.
Novak MA; Rice TA; Michels RG; Auer C
Ophthalmology; 1984 Dec; 91(12):1485-9. PubMed ID: 6521989
[TBL] [Abstract][Full Text] [Related]
76. Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy.
Sato T; Tsuboi K; Nakashima H; Emi K
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):665-671. PubMed ID: 27770210
[TBL] [Abstract][Full Text] [Related]
77. Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.
Yeoh J; Williams C; Allen P; Buttery R; Chiu D; Clark B; Essex R; McCombe M; Qureshi S; Campbell WG
Clin Exp Ophthalmol; 2008 Jul; 36(5):449-54. PubMed ID: 18942219
[TBL] [Abstract][Full Text] [Related]
78. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245
[TBL] [Abstract][Full Text] [Related]
79. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
[TBL] [Abstract][Full Text] [Related]
80. Role of bevacizumab in the prevention of early postoperative haemorrhage after 25-gauge microincision vitrectomy surgery.
Sultan Z; Rizvi SF; Qureshi FM; Mahmood SA
Pak J Med Sci; 2016; 32(5):1184-1187. PubMed ID: 27882018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
